Medical Cannabis put to the test in first ever real-world evidence clinical trial led by UHN

Newswise — (Toronto – July 9, 2020) – Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of continued opioid use. 

The Medical Cannabis Real-World Evidence (MC-RWE) clinical trial will allow patients to select medical cannabis products that are tested, from seed straight through to packaging. Patients using the online portal created by Medical Cannabis by Shoppers, will know exactly what is in their product: how many milligrams of THC and cannabidiol are being consumed, and if it works for them, they can rely on the product being exactly the same, from batch to batch. 

“The challenge with the medical use of cannabis is that physicians and patients are unsure of the quality of products being consumed,” says Dr. Clarke. “For the first time we will have a national repository of data that can provide answers about the effectiveness of these products, to test their claims.” 

Patients in the MC-RWE clinical trial will have access to a wide range of products including dried flower, oil extracts, edibles, and, topical preparations through the portal, which is the online platform for the sale of medical cannabis by Canadian retail pharmacy chain, Shoppers Drug Mart. 

In an industry where standardization is still in its infancy, this study aims to give direction with the same rigour around medical cannabis that is demanded of any other pharmaceutical product. 

“Medical Cannabis by Shoppers is best placed to offer Canadians the reassurance of medical products that have been tested and validated,” says Ken Weisbrod, Vice President, Business Development/Cannabis Strategy, Shoppers Drug Mart. “Our development of a blockchain secured initiative, with TruTrace Technologies Inc., has now been integrated into an operational portal that will provide products with an immutable digital identity, that can capture everything from detailed chemistry down to its DNA.” 

Users of medical cannabis have long been vocal about its efficacy in treating chronic pain. Cannabis has also been championed as an alternative to opioids in the treatment of chronic pain. With anecdotal testimonies in abundance, Dr. Clarke, a key opinion leader in the pain management arena, knows that scientific data is necessary to help patients access alternative pain relief and test these assertions.    

“We need the evidence to help us in prescribing the appropriate validated product, at the right dose, for the right patient,” says Dr. Clarke. “Ensuring quality standards will allow physicians and their patients to be confident about using medical cannabis to treat a wide range of pain-related ailments.”

Dr. Clarke is a staff anesthesiologist, Director, Pain Services, Medical Director of The Pain Research Unit, and, Director of the Good Hope Ehlers Danlos Clinic, UHN.

 

Contacts for HCPs:

  1. For more information, go to the RWE website: mcrwe.ca
  2. Contact the study coordinator or PI at 416-340-4800 x4251 or email at mcrwe@uhn.ca.
  3. If you’re ready to sign on to the e-portal as a recruiting physician go to https://hcp-portal.shoppersdrugmart.ca/

 

Contact for Patients:

  1. For more information please speak to your  doctor to learn if you are eligible to participate or visit mcrwe.ca 

 

 

About University Health Network

University Health Network consists of Toronto General Hospital, recently ranked the #4 Hospital in the World according to Newsweek Magazine, and Toronto Western Hospital, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and the Michener Institute of Education at UHN. The scope of research and complexity of cases at University Health Network has made it a national and international source of discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. University Health Network is a research hospital affiliated with the University of Toronto. www.uhn.ca

Proactive: TruTrace Sees Strong Adoption with Producers

“Over 10 major producers have flocked to the StrainSecure platform to track strains of medical cannabis and verify their authenticity

The company’s StrainSecure track and trace platform provides mandatory testing, DNA-based product validation, and helps with intellectual property protection and product guarantees for patients and customers.

The Vancouver-based firm channels the power of blockchain to fix the grim realities of corrupted supply chains in the medical cannabis industry. It combines the power of big data with the security of blockchain to provide strain identification, registration and verification for cannabis at scale.

The firm’s immutable, cryptographically secure technology is the brainchild of co-founder and chief technology officer Tommy Stephenson, who developed enterprise software platforms over two decades for companies such as Microsoft and Mercedes Benz. The company’s Seattle development center has “a Disney feel” to it with the engineers exuding an “if we can dream it, we can build it” philosophy.

The Seattle team’s goal has been to build a framework to help licensed cannabis producers and micro-cultivators easily and inexpensively move their products through the mandatory testing process. TruTrace places that test data on the blockchain for its own protection and that of the company’s intellectual property.

In this way, the StrainSecure platform establishes an accurate, single source, validated, and permanent account for cannabis strains from seed source to market. A cannabis strain’s genetics are stored into an immutable ledger and information is added during each processing stage.

In short, TruTrace’s seed-to-sale tracking platform tackles two pain points in the cannabis industry: it modernizes the inventory tracking system and provides customers with details about a product’s lab test results and cultivar….”

Find out more read the full article by clicking on the button below.  

Proactive: TruTrace Technologies Strikes License Deal with Logistics Group OrionOne

“TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF), the cannabis-focused blockchain group, has struck a software license deal with logistics group OrionOne Global Inc, which will allow it to widen its client base, the firm said.

OrionOne is a global supply chain provider which has developed a logistics and tracking smart-hub for navigating shipments and logistics.

TruTrace said the deal would allow it to leverage the OrionOne platform to support commercialization of its core products for its customers.

It not only assures the long-term functionality of StrainSecure(TM), but “we believe it will open up market opportunities for TruTrace in other key industries”, Robert Galarza, CEO of TruTrace, told investors in a statement.

“Our core mission was built on traceability of quality assurance and testing details at a very granular level and we believe the incorporation of logistics tracking will significantly expand our client base.”

TruTrace’s platform has been designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharma industries.

“Licensing OrionOne will give TruTrace the ability to maximize its commercial opportunities, as well as begin to expand its offering beyond the cannabis industry,” Tommy Stephenson, the founder and CEO of OrionOne noted.

He said when the firm developed OrionOne over four years ago it was with a macro view of shipping and logistics, which will complement the precise level of detail provided by TruTrace…”

Find out more read the full article by clicking on the button below.  

Seed to Sale Cannabis Journey: Shoppers Drug Mart and PurityIQ, produced by Deloitte

For thousands of years cannabis has been used as a medicinal plant for people’s health and quality of life.

In the recent years we’ve embarked into a new chapter and a brave new market. Join us on this journey and learn about the key players across retail, science, and technology come together to forge a new path to safety and transparency, from seed to sale.  

Retailers like Shoppers Drug Mart have been taking deliberate steps to bring this miracle plant into the marketplace in a safe and secure way. They have partnered with thought leaders across other industries to ensure state of the art testing, data analytics, and a transparent supply chain from seed to sale. Learn more about the key players that have been coming together to lead the charge. 

CSE Entrepreneur Stories: TruTrace Tech. Protects IP and Sends Counterfeiters Packing

We are proud to have our CEO featured in this month’s Entrepreneur Stories, presented by the CSE. They discuss what technologies we are leveraging to help protect IP and make it harder and harder for counterfeiters to infiltrate the markets. They also discuss the dream team in Seattle, the pilot program with Shopper’s in Canada and what the future could hold. 

Here is a short excerpt from the full interview. To read the full interview click here.

“Channeling the power of blockchain

With TruTrace, Galarza now channels the power of blockchain to enhance trust and fix the grim realities of corrupted supply chains in the medical cannabis industry.

In a nutshell, TruTrace combines the power of big data with the security of blockchain to provide strain identification, registration and verification for cannabis at scale.

The firm’s immutable, cryptographically secure technology is the brainchild of Co-Founder and Chief Technology Officer Tommy Stephenson, who developed enterprise software platforms over two decades for companies such as Microsoft and Mercedes Benz.

Galarza says his favourite part of the job is traveling to Seattle to visit the development centre, which has “a Disney feel” to it. The engineers exude an “if we can dream it, we can build it” philosophy, he says.”

Dope Magazine: The Genetics of Cannabis

TruTrace Featured on Dope Magazine:

The Genetics of Cannabis: Trutrace’s Software is Protecting Producers and Patients through Tracking Technology

 
 

“When people hear the word blockchain, they often think of the rise of cryptocurrencies like Bitcoin, but TruTrace Technologies (“TruTrace”) is using blockchain to track cannabis from seed to the hands of medical patients in Canada – specifically from a testing and supply chain perspective. They wanted to develop a dynamic supply chain visibility solution that could implement a blockchain solution into their framework, allowing TruTrace not only to protect the data surrounding cannabis, but cannabis consumers and patients at large.

So, who is validating these transactions? With cryptocurrency, a large group of decentralized miners (millions of computers across the world) track the exchange of cryptocurrency every time it passes “hands,” so to speak. When it comes to tracking cannabis genetics among a myriad of other data points, the blockchain miners with TruTrace ensure validity via a “trusted node network,” according to TruTrace CEO Robert Galarza, who states that the various players (governing bodies) along the way include pharmacies, licensed producers and in this instance, Health Canada. It is not an open mining solution that’s tokenizing the support of the chain itself, but rather a network of stakeholders looking to create a better level of trust when it comes to the sale of medical cannabis in Canada. With TruTrace, the industry stakeholders are the ones who govern the body and manage the ledger. Software solutions and SaaS models can then be built off that particular chain in an effort to access information.

The inspiration behind TruTrace came from an inherent issue that they saw in seed to sale tracking systems without proper inventory identification. They knew that genetics was the key to a larger tracking solution and they knew that the future of medical cannabis across the globe would eventually come down to identifying, tracking and verifying the genetics and source of cannabis strains….”

 

Find out more about our pilot program in Canada, our focus on consumer safety and integrity, and learn about the functionality of the platform as well as the science behind the testing  by reading the FULL article on Dope Magazine – follow the link below